ArticleWorld journal of urology2025

Efficacy and safety of disitamab vedotin in combination with immune checkpoint inhibitors in patients with locally advanced or metastatic urothelial carcinoma.

Ji-Ming Yao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.